1.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LXRX Giù?
Forum
Previsione
Frazionamento azionario
Lexicon Pharmaceuticals Inc Borsa (LXRX) Ultime notizie
Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Institutional & Consistent Profit Alerts - newser.com
What candlestick patterns are forming on Lexicon Pharmaceuticals Inc.Market Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsQuarterly Profit Summary & Weekly High Return Forecasts - newser.com
Using data tools to time your Lexicon Pharmaceuticals Inc. exitJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Published on: 2025-10-24 01:54:11 - newser.com
Is Lexicon Pharmaceuticals Inc. building a consolidation baseDip Buying & Safe Swing Trade Setups - newser.com
Published on: 2025-10-21 14:44:52 - newser.com
Full technical analysis of Lexicon Pharmaceuticals Inc. stockEntry Point & Safe Entry Zone Tips - newser.com
What analysts say about Lexicon Pharmaceuticals Inc stockTrading Volume Trends & Double Or Triple Investment - earlytimes.in
Macro Review: Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Market Overview & Comprehensive Market Scan Reports - nchmf.gov.vn
How analysts rate Lexicon Pharmaceuticals Inc. stock todayWeekly Trend Recap & Long-Term Growth Stock Strategies - nchmf.gov.vn
Activity Recap: How analysts rate Lexicon Pharmaceuticals Inc. stock todayJuly 2025 EndofMonth & Community Trade Idea Sharing - nchmf.gov.vn
Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Pullback Review & AI Optimized Trading Strategy Guides - nchmf.gov.vn
Lexicon Pharmaceuticals Inc Stock Analysis and ForecastSector Leadership Analysis & Affordable Growth Strategies - earlytimes.in
Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit - The Manila Times
Lexicon Pharmaceuticals Advances 10mg Pilavapadin to Phase 3 | LXRX Stock News - Stock Titan
Short interest data insights for Lexicon Pharmaceuticals Inc.2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8% HigherWhat's Next? - MarketBeat
Lexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Down 6.3%Time to Sell? - MarketBeat
Lexicon (LXRX) Engages in Policy Discussion to Tackle Chronic Pa - GuruFocus
Lexicon Pharmaceuticals Hosts Roundtable on Legislative Solutions for Chronic Pain Management - Quiver Quantitative
Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain - MarketScreener
Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People With Chronic Pain - 富途牛牛
Detecting price anomalies in Lexicon Pharmaceuticals Inc. with AIEarnings Beat & Intraday High Probability Alerts - newser.com
Can you recover from losses in Lexicon Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com
Is Lexicon Pharmaceuticals Inc. a candidate for recovery playPortfolio Value Summary & Consistent Income Trade Recommendations - newser.com
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):